Back to funds

Octagon Capital Advisors LP

Updated 6 days ago

Managed by Octagon Capital Advisors Lp • Latest filing Q3 2026

Portfolio value
$750.6M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
98.6%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$823.7M
Q1 2026$903.6M
Q2 2026$1.1B
Q3 2026$750.6M

Top holdings

26 positions as of Q3 2026

View filing
D

DIANTHUS THERAPEUTICS INC

Value
$148.5M
Shares
1.69M
% Port
19.79%
A

ABIVAX SA

Value
$98.3M
Shares
993.0K
% Port
13.10%
D

DEFINIUM THERAPEUTICS INC

Value
$95.6M
Shares
2.51M
% Port
12.73%
C

COGENT BIOSCIENCES INC

Value
$75.2M
Shares
2.35M
% Port
10.02%
A

ARRIVENT BIOPHARMA INC

Value
$64.8M
Shares
2.14M
% Port
8.64%
T

TAYSHA GENE THERAPIES INC

Value
$47.2M
Shares
9.69M
% Port
6.29%
O

OBSIDIAN THERAPEUTICS INC

Value
$33.2M
Shares
2.41M
% Port
4.42%
K

KYMERA THERAPEUTICS INC

Value
$22.9M
Shares
205.0K
% Port
3.05%
I

DISC MEDICINE INC

Value
$17.7M
Shares
270.0K
% Port
2.35%
T

TANGO THERAPEUTICS INC

Value
$15.7M
Shares
630.0K
% Port
2.09%
X

XENON PHARMACEUTICALS INC

Value
$15.6M
Shares
420.0K
% Port
2.08%
A

ADLAI NORTYE GROUP LTD

Value
$15M
Shares
934.7K
% Port
1.99%
M

MIRUM PHARMACEUTICALS INC

Value
$14.5M
Shares
169.4K
% Port
1.93%
A

AKTIS ONCOLOGY INC

Value
$13.9M
Shares
713.0K
% Port
1.85%
?
15.N/A

PALISADE BIO INC

Value
$13.9M
Shares
10.28M
% Port
1.85%
?
16.N/A

ERASCA INC

Value
$10.6M
Shares
720.0K
% Port
1.41%
B

BIOAGE LABS INC

Value
$9.2M
Shares
1.30M
% Port
1.23%
P

PHARVARIS N V

Value
$7.9M
Shares
249.0K
% Port
1.05%
?
19.N/A

GYRE THERAPEUTICS INC

Value
$7M
Shares
954.4K
% Port
0.93%
D

DBV TECHNOLOGIES S A

Value
$6.8M
Shares
574.2K
% Port
0.90%

Explore